Form 4 for JSPR Jasper Therapeutics, Inc.
Accepted 2024-06-12 00:00:00 ET · period of report 2024-06-12 · accession 0001213900-24-052215 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-12 | 2024-06-12 | JSPR | Mahal Jeetinder Singh | COO | S - Sale+OE | $24.16 | -900 | 25.0K | -3% | -$21.7K |
| D | 2024-06-12 | 2024-06-12 | JSPR | Mahal Jeetinder Singh | COO | M - OptEx | $7.10 | +900 | 25.9K | +4% | +$6,390 |
| D | 2024-06-12 | 2024-06-12 | JSPR | Mahal Jeetinder Singh | COO | M - OptEx | $0.00 | +900 | 15.6K | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Voting Common Stock | 2024-06-12 | S | D | 900 | $24.16 | 25,009 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $23.975 to $24.555, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased or sold at each separate price. |
| 2 | Common | Voting Common Stock | 2024-06-12 | M | A | 900 | $7.10 | 25,909 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-06-12 | M | A | 900 | $0.00 | 15,572 | D | $7.10 · — to 2030-05-31 | 900 Voting Common Stock | (F3) 25% of the original number of shares subject to the option vested on December 12, 2020, and 1/48th of the original number of shares subject to the option vested monthly thereafter. |